Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Transform your credit card points into charitable contributions. Discover how to donate your rewards and support meaningful causes in your community.
17,798 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Marvell Technology defied earlier sell-offs tied to fears of losing Amazon and Microsoft to rivals, reporting strong ...
Figma posted impressive numbers in early 2026, yet the stock slumped. This article breaks down the drivers behind fig...
Oil-driven demand shifts could threaten McDonald’s traffic and same-store sales, even as its franchise-heavy model cu...
Ark Invest's Cathie Wood is signaling a bold stance by scooping up Coinbase and Circle during a crypto sell-off. This...
U.S. stocks declined as oil surged on Middle East tensions, with the S&P 500 and tech shares under pressure. Markets ...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
Grocery Outlet faces supply-chain and affordability pressures, while Scholastic gauges upside; analysts adjust target...
July 16 could be a pivotal date for Nvidia and the broader AI chip ecosystem. This guide explains why Nvidia investor...
A tentative Department of Justice settlement keeps Live Nation's Ticketmaster in place but imposes reforms that could...
A founder sold a meaningful chunk of stock, but does that signal trouble or a routine liquidity move? This article br...
Investors chase stocks with accelerating growth and clear catalysts. This guide explains how to identify a supercharg...